Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 5676 - 5700 of 6033 in total
Angelica dahurica root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Investigational
C-CAR039 is an autologous Chimeric Antigen Receptors (CAR) T-cell therapy expressing CD19/CD20 bi-specific CAR.
Investigational
Mitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.
Investigational
Interleukin 7 has been used in trials studying the treatment of Metastatic Breast Cancer.
Investigational
Investigational
GTP-506 is a gene therapy formed by two vectors, a nuclease vector targeting gene editing in the well-characterized PCSK9 gene locus and a therapeutic donor vector that inserts the OTC gene to provide the desired genetic correction.
Investigational
CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP).
Investigational
A pyrimidine ribonucleoside 5'-monophosphate having cytosine as the nucleobase.
Experimental
Displaying drugs 5676 - 5700 of 6033 in total